See more : Torrent Capital Ltd. (TRRPF) Income Statement Analysis – Financial Results
Complete financial analysis of Zymergen Inc. (ZY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zymergen Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- MultiChoice Group Limited (MCHOY) Income Statement Analysis – Financial Results
- Changchai Company, Limited (200570.SZ) Income Statement Analysis – Financial Results
- Fredun Pharmaceuticals Limited (FREDUN.BO) Income Statement Analysis – Financial Results
- Freehold Royalties Ltd. (0UWL.L) Income Statement Analysis – Financial Results
- Alamos Gold Inc. (AGI.TO) Income Statement Analysis – Financial Results
Zymergen Inc. (ZY)
About Zymergen Inc.
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.
| Metric | 2021 | 2020 | 2019 |
|---|---|---|---|
| Revenue | 16.74M | 13.28M | 15.42M |
| Cost of Revenue | 69.72M | 84.82M | 102.64M |
| Gross Profit | -52.98M | -71.53M | -87.22M |
| Gross Profit Ratio | -316.42% | -538.50% | -565.67% |
| Research & Development | 159.12M | 90.85M | 50.72M |
| General & Administrative | 83.01M | 60.08M | 61.25M |
| Selling & Marketing | 23.65M | 18.63M | 24.14M |
| SG&A | 106.66M | 78.70M | 85.39M |
| Other Expenses | 175.51M | 0.00 | 0.00 |
| Operating Expenses | 265.78M | 169.56M | 136.10M |
| Cost & Expenses | 335.50M | 254.37M | 238.74M |
| Interest Income | 64.00K | 492.00K | 4.92M |
| Interest Expense | 14.71M | 10.96M | 2.94M |
| Depreciation & Amortization | 20.70M | 18.71M | 15.20M |
| EBITDA | -326.33M | -232.58M | -218.65M |
| EBITDA Ratio | -1,949.08% | -1,750.80% | -1,418.08% |
| Operating Income | -347.03M | -241.09M | -237.11M |
| Operating Income Ratio | -2,072.68% | -1,814.88% | -1,537.80% |
| Total Other Income/Expenses | -14.71M | -21.15M | 318.00K |
| Income Before Tax | -361.73M | -262.24M | -236.80M |
| Income Before Tax Ratio | -2,160.51% | -1,974.13% | -1,535.74% |
| Income Tax Expense | 51.00K | -49.00K | 8.00K |
| Net Income | -361.79M | -262.19M | -236.80M |
| Net Income Ratio | -2,160.81% | -1,973.76% | -1,535.79% |
| EPS | -4.87 | -2.68 | -2.42 |
| EPS Diluted | -4.87 | -2.68 | -2.42 |
| Weighted Avg Shares Out | 74.31M | 97.94M | 97.94M |
| Weighted Avg Shares Out (Dil) | 74.31M | 97.94M | 97.94M |
ZY INVESTOR DEADLINE: Hagens Berman Encourages Zymergen (ZY) Investors with Losses to Contact Firm's Attorneys BEFORE OCTOBER 4TH DEADLINE in Securities Fraud Lawsuit
San Francisco, California--(Newsfile Corp. - September 29, 2021) - Hagens Berman urges Zymergen Inc. (NASDAQ: ZY) investors with significant losses to submit your losses now.Class Period: Apr. 20, 2021 - Aug. 4, 2021Lead Plaintiff Deadline: Oct. 4, 2021Visit: www.hbsslaw.com/investor-fraud/ZY Contact...
ZY LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Zymergen Inc.
New York, New York--(Newsfile Corp. - September 28, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Zymergen Inc. ("Zymergen") (NASDAQ: ZY) . This lawsuit is...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Zymergen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 4, 2021 - ZY
New York, New York--(Newsfile Corp. - September 28, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Zymergen Inc. ("Zymergen") (NASDAQ: ZY) This lawsuit is...
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zymergen Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 28, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Zymergen Inc. ("Zymergen" or "the Company") (NASDAQ: ZY) for violations of the...
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zymergen Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 28, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Zymergen Inc. ("Zymergen" or "the Company") (NASDAQ: ZY) for violations of the...
ZY ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 4, 2021 in the Class Action Filed on Behalf of Zymergen Inc. Limited Shareholders
New York, New York--(Newsfile Corp. - September 28, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zymergen Inc. (NASDAQ: ZY) alleging that the Company violated federal securities laws.This...
Zymergen Inc. Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Deadline in Securities Fraud Class Action Lawsuit
RADNOR, Pa., Sept. 28, 2021 /PRNewswire/ -- September 28, 2021 – The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Zymergen Inc. (NASDAQ: ZY) ("Zymergen") on behalf of...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Zymergen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 4, 2021 - ZY
New York, New York--(Newsfile Corp. - September 27, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Zymergen Inc. ("Zymergen") (NASDAQ: ZY) This lawsuit is...
LAWSUITS FILED AGAINST ZY, YALA and SAVA - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / September 27, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders...
ZYMERGEN INC. (ZY) CLASS ACTION LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Zymergen, Inc.
New York, New York--(Newsfile Corp. - September 27, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed...
Source: https://incomestatements.info
Category: Stock Reports